Welcome to our dedicated page for Northrop Grumman SEC filings (Ticker: NOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Northrop Grumman Corporation (NOC) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. Northrop Grumman is a global aerospace and defense technology company, and its filings provide structured insight into its financial performance, capital structure, governance, and key agreements.
Recent Form 8-K filings illustrate the types of information investors can expect. A July 22, 2025 Form 8-K reports that Northrop Grumman issued an earnings release for the quarter ended June 30, 2025, while an October 21, 2025 Form 8-K notes the release of financial results for the quarter ended September 30, 2025. These current reports reference earnings releases furnished as exhibits, which complement the company’s quarterly reports on Form 10-Q and annual reports on Form 10-K that are also accessible through EDGAR.
Another Form 8-K dated September 2, 2025 describes a material definitive agreement: a five-year senior unsecured revolving credit facility intended to support the company’s commercial paper program and other general corporate purposes. The filing outlines key covenants, including a maximum consolidated debt-to-capitalization ratio and customary events of default. A November 6, 2025 Form 8-K details a chief financial officer transition and related compensation decisions approved by the Compensation and Human Capital Committee.
On this page, Stock Titan surfaces such filings in real time and applies AI-powered summaries to explain the significance of documents like 10-K annual reports, 10-Q quarterly reports, and 8-K current reports. Users can also review disclosures related to material agreements and leadership changes, and locate information that may be relevant to insider transactions reported on Form 4. The goal is to make Northrop Grumman’s regulatory record easier to navigate by highlighting key sections and translating technical language into more accessible explanations.
Northrop Grumman Corporation outlines its 2025 business, scale and risks as a leading global aerospace and defense technology company focused on U.S. and international security customers, especially the U.S. Department of War and intelligence community.
The company operates through four segments — Aeronautics Systems, Defense Systems, Mission Systems and Space Systems — covering aircraft, missiles, space systems, sensors, cyber and command-and-control solutions, with a mix of open and restricted programs.
In 2025, total sales were $ in millions: U.S. Government $35,183, International $5,990, Other $781, Total $41,954, split about evenly between cost-type and fixed-price contracts, and U.S. government sales represented 84% of revenue. Backlog reached $95.7 billion, up from $91.5 billion a year earlier, indicating multi‑year revenue visibility.
As of June 30, 2025, non‑affiliate market value of common stock was about $71.5 billion, and as of January 22, 2026 there were 141,921,621 shares outstanding. The company employed about 95,000 people at year‑end 2025 after hiring roughly 7,500 in 2025, and discusses extensive risk factors spanning dependence on U.S. defense budgets, cost estimation and contract risk, macroeconomic and supply chain pressures, cybersecurity, environmental obligations and evolving regulations.
Northrop Grumman Corporation filed a current report to note that it has released its financial results for the fourth quarter and full year ended December 31, 2025. On January 27, 2026, the company issued an earnings release titled “Northrop Grumman Reports Fourth Quarter and Full-Year 2025 Financial Results,” which is included as Exhibit 99 to this report. The filing identifies this earnings release as furnished information on results of operations and financial condition, rather than detailed financial statements within the report itself.
Northrop Grumman Corporation’s Chief Financial Officer, John Greene, filed an initial ownership report stating that he beneficially owns no company securities. The Form 3 shows that as of 01/07/2026, he held 0 shares of common stock directly and reported no derivative securities such as options or warrants. A remark reiterates that no securities are beneficially owned, and a power of attorney is noted as an exhibit, indicating that the filing was submitted on his behalf by an attorney-in-fact.
Northrop Grumman (NOC) Chair, CEO and President Kathy J. Warden reported two open-market stock sales under a pre-arranged Rule 10b5-1 trading plan. On January 5, 2026, she sold 7,000 shares of Northrop Grumman common stock at $600 per share. On January 6, 2026, she sold an additional 3,000 shares at $615 per share. These transactions were executed pursuant to a Rule 10b5-1 plan adopted on September 2, 2025. After the reported sales, she directly beneficially owns 191,602.4 shares of Northrop Grumman common stock.
NOC shareholder Kathy J. Warden filed a notice to sell 3,000 shares of common stock with an aggregate market value of $1,845,000 through Fidelity Brokerage Services LLC, with an approximate sale date of January 6, 2026 on the NYSE.
The filing notes that there were 142,720,067 shares of common stock outstanding. The 3,000 shares to be sold were acquired on February 14, 2024 through restricted stock vesting from the issuer as compensation, with payment also dated February 14, 2024. Over the past three months, Warden previously sold 7,000 common shares on January 5, 2026 for gross proceeds of $4,200,000.
Northrop Grumman Corporation director reports routine equity compensation activity. On 12/31/2025, the director acquired 64 shares of Northrop Grumman common stock at $570.21 per share through deferral into a stock unit account under the company’s 2024 Long-Term Incentive Stock Plan, in a transaction exempt under Rule 16b-3. Following this transaction, the director beneficially owned 2,257 shares in the stock unit account. The filing notes that dividends credited on shares in this account are exempt from Section 16 and were not required to be reported.
Northrop Grumman reported an equity transaction by a company director. On 12/31/2025, the director acquired 81 shares of Northrop Grumman common stock at $570.21 per share. These shares were deferred into a stock unit account under the company’s 2024 Long-Term Incentive Stock Plan in a transaction that is exempt under Rule 16b-3.
Following this transaction, the director beneficially owned 10,963 shares of common stock in the stock unit account, which includes dividends credited under the plan. Dividends earned on these stock units were exempt from Section 16 reporting and therefore were not required to be reported as separate transactions.
Northrop Grumman insider filed a notice to sell company stock under Rule 144. The filing covers 7,000 shares of common stock, to be sold through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of 4,200,000.00. The notice lists 142,720,067 shares outstanding of the same class of stock.
The shares planned for sale come from restricted stock vesting awards received from the issuer as compensation. The insider acquired 4,621 shares on 02/14/2024 and 2,379 shares on 02/16/2024, both labeled as compensation. The approximate date of sale is given as 01/05/2026. By signing, the seller represents they are not aware of undisclosed material adverse information about Northrop Grumman’s operations.
Northrop Grumman Corporation executive CVP & President, Mission Systems reported a small open-market stock sale. On December 9, 2025, the reporting person sold 84 shares of common stock at a price of $555.35 per share, coded as a sale transaction. This trade was made under a pre-arranged Rule 10b5-1 trading plan adopted on February 11, 2025.
After this transaction, the reporting person beneficially owned 403.91 shares of Northrop Grumman common stock directly. In addition, 114.1531 shares were held indirectly through the Northrop Grumman Savings Plan, a qualified defined contribution plan, as of December 9, 2025, where unit accounting can change reported units without a new purchase or sale.
A holder of NOC common stock has filed a notice of proposed sale on Form 144. The filing covers the planned sale of 84 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of 46649.40. The securities were acquired on 12/05/2025 via restricted stock vesting from the issuer as compensation, with payment also dated 12/05/2025. The filing notes that 142,720,067 shares of this class were outstanding, providing context for the size of the planned sale.
FAQ
What is the current stock price of Northrop Grumman (NOC)?
What is the market cap of Northrop Grumman (NOC)?
